About

The Models to Medicine Center harnesses campus research strengths in life sciences to foster translational applications, create synergistic ties with industry, and improve the training of future life scientists, especially those who will join the workforce in the commonwealth.

Established in 2013, the center advances translational research at UMass and supports life sciences driven economic development. The Models to Medicine Center is one of three centers supported with more than $150 million in capital investments to date by the Massachusetts Life Sciences Center and UMass Amherst as part of the university’s Institute for Applied Life Sciences (IALS).
 

M2M Leadership

• Peter Chien, Biochemistry & Molecular Biology, Director
• Jeanne Hardy, Chemistry, Associate Director
• Sloan Siegrest, Microbiology, Associate Director

M2M Steering Committee/Theme Leaders

• Peter Chien, Biochemistry & Molecular Biology
• Ned Debold, mUscleMASS
• Jeanne Hardy, Chemistry
• Dan Hebert, Protein Homeostasis
• Abbie Jensen, Cellular Dynamics
• D. Joseph Jerry, Engineered Models and Mechanisms in Cancer (EM²C)
• Li-Jun Ma, Plant and Microbial Innovation
• David Moorman, Mechanisms of Neural Function & Dysfunction
• Barbara Osborne, Veterinary and Animal Sciences
• Shelly Peyton, Chemical Engineering
• Leonid Pobezinsky, Infection & Immunity
• Peter Reinhart, IALS
• Maria Santore, Membranes in Biology & Medicine
• Celia Schiffer, UMMS
• Jungwoo Lee, Biomaterials for Devices and Regenerative Medicine (BDRM)
• Sloan Siegrist, Microbiome, Microbes & Infectious Diseases
• Pablo Visconti, Contraception, Reproduction Assistance Technologies and Embryology (CReATE)